Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.
Persico, M
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. [electronic resource] - Gut Apr 2008 - 507-15 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1468-3288
10.1136/gut.2007.129478 doi
Adult
Aged
Antiviral Agents--therapeutic use
Biomarkers--blood
Cell Line, Transformed
Drug Therapy, Combination
Female
Gene Expression Profiling--methods
Genetic Markers
Haplotypes
Hepatitis C, Chronic--drug therapy
Humans
Interferon-alpha--therapeutic use
Male
Middle Aged
Polymorphism, Single Nucleotide
Prognosis
RNA, Messenger--genetics
Ribavirin--therapeutic use
Suppressor of Cytokine Signaling 3 Protein
Suppressor of Cytokine Signaling Proteins--blood
Treatment Failure
Treatment Outcome
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. [electronic resource] - Gut Apr 2008 - 507-15 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1468-3288
10.1136/gut.2007.129478 doi
Adult
Aged
Antiviral Agents--therapeutic use
Biomarkers--blood
Cell Line, Transformed
Drug Therapy, Combination
Female
Gene Expression Profiling--methods
Genetic Markers
Haplotypes
Hepatitis C, Chronic--drug therapy
Humans
Interferon-alpha--therapeutic use
Male
Middle Aged
Polymorphism, Single Nucleotide
Prognosis
RNA, Messenger--genetics
Ribavirin--therapeutic use
Suppressor of Cytokine Signaling 3 Protein
Suppressor of Cytokine Signaling Proteins--blood
Treatment Failure
Treatment Outcome